1. Home
  2. ELWT vs MREO Comparison

ELWT vs MREO Comparison

Compare ELWT & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ELWT

Elauwit Connection Inc.

HOLD

Current Price

$7.16

Market Cap

58.5M

ML Signal

HOLD

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

HOLD

Current Price

$0.32

Market Cap

53.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELWT
MREO
Founded
2002
2015
Country
United States
United Kingdom
Employees
34
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.5M
53.4M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
ELWT
MREO
Price
$7.16
$0.32
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
$12.00
$1.50
AVG Volume (30 Days)
47.5K
1.8M
Earning Date
05-15-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$500,000.00
Revenue This Year
$28.81
$5,184.20
Revenue Next Year
$70.70
$55.51
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.11
$0.20
52 Week High
$9.72
$2.37

Technical Indicators

Market Signals
Indicator
ELWT
MREO
Relative Strength Index (RSI) 52.38 54.15
Support Level $6.61 $0.29
Resistance Level $7.36 $0.36
Average True Range (ATR) 0.69 0.03
MACD 0.12 0.00
Stochastic Oscillator 53.28 74.35

Price Performance

Historical Comparison
ELWT
MREO

About ELWT Elauwit Connection Inc.

Elauwit Connection Inc is a provider of broadband Internet networks for the multifamily and student housing property sector. It designs, installs, operates, and maintains new fiber-optic and WiFi networks throughout each contracted property. Once installed, property owners begin selling Internet connectivity over Elauwit's network directly to their residents at monthly prices and terms of their choosing. Elauwit, in turn, provides all resident activation, onboarding, customer support, and network monitoring and maintenance services in exchange for a fixed monthly fee based on the number of units in the property times a monthly per-unit wholesale price. Its contracts with property owners generally have five to eight-year terms. Geographically, the company mainly operates in the U.S.

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Share on Social Networks: